Puma Biotechnology, Inc. ( PBYI) - Key Metrics
PBYI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.11 | $0.16 | $0.03 | $0.03 |
| 2026Q1 | $0.88 | -$0.07 | $0.30 | $0.30 |
| 2025Q4 | $1.50 | $0.27 | $0.29 | $0.29 |
| 2025Q3 | $1.08 | $0.18 | $0.19 | $0.19 |
| 2025Q2 | $1.06 | $0.12 | $0.28 | $0.28 |
PBYI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 12.67 |
| 2026Q1 | 0% | -21.65 |
| 2025Q4 | 0% | 5.51 |
| 2025Q3 | 0% | 7.38 |
| 2025Q2 | 0% | 7.15 |
PBYI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.39% | 0% |
| 2026Q1 | 4.74% | 0% |
| 2025Q4 | 4.83% | 0% |
| 2025Q3 | 3.62% | 0% |
| 2025Q2 | 8.25% | 0% |
PBYI
Price: $9.83
52 week price:
Earnings Per Share: 0.51 USD
P/E Ratio: 17.45
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 234700
Ebitda: -76.5 millionMarket Capitalization: 489.1 million